ANDATOPICALLOTION
Approved
Jun 2005
Lifecycle
Post-LOE
Competitive Pressure
30/100
Data completeness
2/8 — Basic
CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (betamethasone dipropionate; clotrimazole) by Sandoz is [see ] . First approved in 2005.
Drug data last refreshed 18h ago
Mechanism of Action
[see ] . Betamethasone dipropionate is a corticosteroid. Corticosteroids play a role in cellular signaling, immune function, inflammation, and protein regulation; however, the precise mechanism of action for the treatment of tinea pedis, tinea cruris and tinea corporis is unknown.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Company
Sandoz
Austria - Kundl
Worked on CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE at Sandoz? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.